VLA4-nanoparticles hijack cell adhesion mediated drug resistance (CAM-DR) to target refractory myeloma cells and prolong survival

BACKGROUND. In multiple myeloma (MM), drug resistant cells underlie relapse or progression following chemotherapy. Cell adhesion mediated-drug resistance (CAM-DR) is an established mechanism used by MMC to survive chemotherapy and its markers are upregulated in residual disease. The integrin VLA4 (α...

詳細記述

保存先:
書誌詳細
出版年:Clin Cancer Res
主要な著者: Fontana, Francesca, Scott, Michael J., Allen, John S., Yang, Xiaoxia, Cui, Grace, Pan, Dipanjan, Yanaba, Noriko, Fiala, Mark A., O’Neal, Julie, Schmieder-Atteberry, Anne H., Ritchey, Julie, Rettig, Michael, Simons, Kathleen, Fletcher, Steven, Vij, Ravi, DiPersio, John F., Lanza, Gregory M.
フォーマット: Artigo
言語:Inglês
出版事項: 2020
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC8026499/
https://ncbi.nlm.nih.gov/pubmed/33355244
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-20-2839
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料